🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tibor Keler

Celldex Therapeutics (United States)

ORCID: 0000-0003-1757-4230
Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors”.

Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005147
N/A
1.7DataRank · unranked
66 citations

Michael J. Pishvaian, Margaret K. Callahan, Amy Weise, Branimir I. Šikić, Osama E. Rahma +19 more

Tissue-specific modifier alleles determine Mertk loss-of-function traits

eLife(2022)10.7554/elife.80530
N/A
1.5DataRank · unranked
43 citations

María E. Mercau, Marleen Ansems, Lindsey D. Hughes, James Nevin, Emily Alberto +13 more

FLT3 ligand (CDX-301) and stereotactic radiotherapy for advanced non-small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9618
N/A
0.633DataRank · unranked
13 citations

Balázs Halmos, Madhur Garg, Jeffrey M. Levsky, Haiying Cheng, Rasim Gucalp +8 more

mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010408
N/A
0.353DataRank · unranked
7 citations

Junko Matsuzaki, Mark D. Long, Spencer R. Rosario, Thinle Chodon, Takemasa Tsuji +14 more

Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3693
N/A
0.345DataRank · unranked
9 citations

Karen A. Autio, Christopher R. Cabanski, Kristopher Wentzel, Julie N. Graff, Terence W. Friedlander +19 more

CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunity

Science Immunology(2025)10.1126/sciimmunol.adz2294
N/A
0.104DataRank · unranked
1 citations

Erika J. Crosby, David T. Severson, Timothy N. Trotter, Jason McBane, Li-Chung Tsao +18 more

Revitalizing systemic immune responses in advanced NSCLC using FLT3L and SBRT

medRxiv(2025)10.1101/2025.01.29.25321332
N/A
0DataRank · unranked
1 citations

Nitin Ohri, Shin Foong Ngiow, Balázs Halmos, Wumesh KC, Madhur Garg +16 more

A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer

Cancer Immunology Immunotherapy(2021)10.1007/s00262-021-02936-1
N/A
0DataRank · unranked
13 citations

Cheryl Eppolito, Anthony Miliotto, Kelly L. Singel, Kyle B. Stephenson, Amit A. Lugade +7 more

A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas

Neuro-Oncology(2023)10.1093/neuonc/noad185
N/A
0DataRank · unranked
17 citations

Hirokazu Ogino, Nicholas Butowski, Meghan Tedesco, David R. Gibson, Payal Watchmaker +21 more

Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s

Nature Communications(2020)10.1038/s41467-020-19192-z
N/A
0DataRank · unranked
134 citations

Mark D. Long, Tibor Keler, Henry C. Marsh, Hans Minderman, Scott I. Abrams +3 more